It has been recognized that Wnt/β-catenin/TCF-4 pathway is often aberrantly activated in gastric cancer (Zhuang et al., 2106), in which β-catenin/TCF-4 interaction occupies an important role. This evidence concerns the gene TCF4 and gastric cancer.